Wisniewski Raphael 4
4 · Axonics Modulation Technologies, Inc. · Filed Jan 22, 2020
Insider Transaction Report
Form 4
Wisniewski Raphael
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-17$31.51/sh−164,739$5,191,486→ 3,092,722 total(indirect: See footnote) - Sale
Common Stock
2020-01-22$31.54/sh−135,261$4,266,389→ 2,957,461 total(indirect: See footnote)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $31.50 to $31.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]2,224,128 shares are held of record by BioDiscovery 4 FCPR ("BioDiscovery") and 733,333 shares are held of record by BioDiscovery 5 ("BioDiscovery 5"). Andera Partners ("Andera") is the manager of BioDiscovery and BioDiscovery 5 and may be deemed to have sole voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5. The reporting person is a director of the Issuer and is a partner of Andera, and may be deemed to share voting and dispositive power over the shares held by BioDiscovery and BioDiscovery 5. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]This transaction was executed in multiple trades at prices ranging from $31.50 to $32.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.